Page last updated: 2024-12-10

at 61

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

AT 61: a phenylpropenamide derivative; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3000232
CHEMBL ID88198
SCHEMBL ID7080587
SCHEMBL ID7080581
MeSH IDM0300981

Synonyms (15)

Synonym
CHEMBL88198
LS-14861
at-61
300669-68-5
benzamide, n-[2-chloro-2-phenyl-1-(1-piperidinylcarbonyl)ethenyl]-
n-[(e)-2-chloro-2-phenyl-1-(piperidine-1-carbonyl)vinyl]benzamide
n-[1-(bromophenylmethylene)-2-oxo-2-piperidylethyl]benzamide
at 61
n-[(e)-1-chloro-3-oxo-1-phenyl-3-piperidin-1-ylprop-1-en-2-yl]benzamide
n-(1-(bromophenylmethylene)-2-oxo-2-piperidylethyl)benzamide
benzamide, n-(2-chloro-2-phenyl-1-(1-piperidinylcarbonyl)ethenyl)-
SCHEMBL7080587
SCHEMBL7080581
at61
(e)-n-(1-chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" These mt-QSARs offer also a good opportunity to construct drug-drug Complex Networks (CNs) that can be used to explore large and complex drug-viral species databases."( Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID86363Reduction of viable cell numbers by 50% was evaluated by HepAD38 cellular assay2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID147705Inhibition of Newcastles disease virus replication by 50% (no effect at this concentration)2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID392509Antiviral activity against Hepatitis B virus2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
AID86024Inhibition of HSV-1 replication by 50% (no effect at this concentration)2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID81419Inhibition of HIV-1 replication by 50% (no effect at this concentration)2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID86362Concentration which inhibits hepatitis B virus replication in the HepAD38 cell line.2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID86846Inhibition of Duck HBV replication by 50% (no effect at this concentration)2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID216378Inhibition of Vesicular stomatis virus replication by 50% (no effect at this concentration)2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID86360Inhibition of hepatitis B virus replication in the HepAD38 cell line.2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
AID608399Antiviral activity against HBV infected in human HepAD38 cells assessed as inhibition of viral DNA synthesis up to 100 uM after 3 days2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs.
AID86856Inhibition of Woodchuck HBV replication by 50% (no effect at this concentration)2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.65 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index34.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]